Revance Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Revance Therapeutics's balance sheet done over the years? Its assets were worth $478,454,000 last year, which is less than in the previous period. 132% of Revance Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $630,058,000, which means an increase by 11% compared compared to last year.
Debt to Assets
| 2014 | 192469000 | 16.1M | 8.36% |
|---|---|---|---|
| 2015 | 275822000 | 22.57M | 8.18% |
| 2016 | 204360000 | 27.28M | 13.35% |
| 2017 | 295699000 | 26.85M | 9.08% |
| 2018 | 226348000 | 80.72M | 35.66% |
| 2019 | 340287000 | 114.79M | 33.74% |
| 2020 | 720220000 | 345.93M | 48.03% |
| 2021 | 531163000 | 462.69M | 87.11% |
| 2022 | 581900000 | 569.3M | 97.83% |
| 2023 | 478454000 | 630.05M | 131.69% |
RVNC Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 137.32M | 108.96M | 110.62M | 333.55M | 171.16M | 73.25M | 282.89M | 63.50M | 201.61M | 171.03M |
Short term investments | 116.58M | 231.74M | 114.44M | 102.94M | 118.95M | 102.55M | 0 | 122.02M | 50.68M | 0 |
Net receivables | 27.67M | 11.33M | 3.34M | 1.82M | 0 | 27M | 48K | 6.02M | 158K | 300K |
Inventory | 45.57M | 18.32M | 10.15M | 5.87M | 0 | 0 | 1 | 978K | 1.23M | 1.16M |
Other current assets | 11.69M | 4.35M | 7.54M | 5.79M | 6.48M | 5.11M | 1.82M | 163K | 1.50M | 1.39M |
Total current assets | 338.86M | 374.72M | 246.11M | 450.00M | 296.60M | 207.92M | 285.21M | 192.69M | 253.96M | 172.73M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 90.20M | 67.75M | 69.00M | 47.13M | 41.28M | 14.44M | 9.25M | 10.58M | 19.70M | 19.27M |
Goodwill | 0 | 77.17M | 146.96M | 146.96M | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 9.80M | 27.00M | 55.33M | 71.34M | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 6.87M | 6.05M | 5.04M | 3.44M | 730K | 0 | 580K | 0 | 1.75M | 0 |
Other non-current assets | 32.70M | 35.23M | 13.74M | 4.77M | 1.66M | 3.97M | 658K | 1.08M | 400K | 464K |
Total non-current assets | 139.58M | 207.17M | 285.04M | 270.21M | 43.68M | 18.42M | 10.48M | 11.66M | 21.85M | 19.73M |
Total assets | 478.45M | 581.9M | 531.16M | 720.22M | 340.28M | 226.34M | 295.69M | 204.36M | 275.82M | 192.46M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 10.73M | 6.86M | 9.36M | 7.85M | 7.91M | 8.58M | 11.51M | 11.75M | 5.54M | 3.69M |
Short term debt | 10.85M | 4.91M | 4.74M | 4.43M | 3.47M | 14.40M | 1.87M | 3.47M | 3.13M | 2.94M |
Total current liabilities | 89.22M | 75.68M | 67.28M | 60.96M | 40.97M | 31.97M | 20.90M | 19.64M | 12.03M | 10.23M |
| Non-current liabilities: | ||||||||||
Long term debt | 467.58M | 413.55M | 319.76M | 207.67M | 25.87M | 0 | 0 | 1.87M | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 2.83M | 1.48M | 1.48M | -180.52M | 47.94M | 6.07M | 5.95M | 5.77M | 10.53M | 5.86M |
Total non-current liabilities | 540.83M | 493.61M | 395.40M | 284.96M | 73.81M | 48.75M | 5.95M | 7.64M | 10.53M | 5.86M |
Total liabilities | 630.05M | 569.3M | 462.69M | 345.93M | 114.79M | 80.72M | 26.85M | 27.28M | 22.57M | 16.1M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |